Dr. Carla Casulo, MD

Dr. Casulo practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Casulo's NPI, 1942338629, was assigned on March 2, 2007. Dr. Casulo graduated from SUNY Downstate Health Sciences University in 2004. Dr. Casulo's New York license number on file is 248510.

Dr. Casulo's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Casulo's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Casulo is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Casulo to 2 more hospitals, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Casulo practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Casulo's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Casulo is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Casulo's licenses on file in 2 states: New York and Connecticut.

Dmand AI lists lymphoma among the conditions Dr. Casulo treats.

CMS data shows 389 Medicare services from Dr. Casulo across 4 procedure codes in 2024, for 103 Medicare patients. Medicare paid $24,675 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Dr. Casulo in 2024. The largest group is 65 to 74, with 45 patients. 55% of them have high blood pressure, and 55% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Casulo's median patient age at 67, with 50% women.

In 2024, Dr. Casulo wrote 260 Medicare Part D claims for 51 patients. 86% of them were for generic drugs. CMS names the drug for 166 of them, across 6 drugs with 11 or more claims each, at $324,073 in total drug cost. In 2023, CMS named 164 claims across 5 drugs.

Dr. Casulo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Casulo as offering telehealth.

Dmand AI links 67 papers to Dr. Casulo, published from 2012 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Follicular and Rituximab. Dr. Casulo has published most often in Clin Lymphoma Myeloma Leuk. Dr. Casulo's most frequent co-authors are Paul Michael Barr, MD, Brad Steven Kahl, MD and Andrew D. Zelenetz, MD.

Dmand AI links Dr. Casulo to 5 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma and Disease Attributes. University of Rochester sponsors the most, 2. Open Payments lists research payments to Dr. Casulo that name 1 trial.

CMS Open Payments shows 69 general payments to Dr. Casulo from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $29,745. It also lists 10 research payments totaling $22,008 from 2017 to 2024, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Casulo, most recently CMS Stage 1 EHR in 2012.

Dr. Casulo graduated from SUNY Downstate Health Sciences University in 2004. Dr. Casulo is a member of ASCO and ASH.

Dr. Casulo is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and MVP Health Care. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.